IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes
暂无分享,去创建一个
W. Leonard | J. Brady | C. Pise-Masison | P. Kovanen | M. Berg | Hai-Hui Xue | Michael F. Radovich | Hai-hui Xue
[1] Richard Murray,et al. IL-7 is critical for homeostatic proliferation and survival of naïve T cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] W. Leonard,et al. The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation , 2001 .
[3] D. Largaespada,et al. Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor , 2000, The Journal of experimental medicine.
[4] Heinz Baumann,et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin , 2000, Nature Immunology.
[5] L. Toledo,et al. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. , 2000, Structure.
[6] W. Leonard,et al. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines , 2000, Oncogene.
[7] P. Marrack,et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. , 2000, Science.
[8] J. Altman,et al. Cutting Edge: Increased Expression of Bcl-2 in Antigen-Specific Memory CD8+ T Cells1 , 2000, The Journal of Immunology.
[9] D. Baltimore,et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. , 1999, Immunity.
[10] K. Muegge,et al. Interleukin-7: physiological roles and mechanisms of action. , 1999, Cytokine & growth factor reviews.
[11] J. Ihle,et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. , 1999, Immunity.
[12] R. Perlmutter,et al. Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. , 1999, Journal of immunology.
[13] W. Leonard,et al. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity. , 1999, Journal of Immunology.
[14] Steven F. Ziegler,et al. Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.
[15] W. Leonard,et al. Functional Cooperation of the Interleukin-2 Receptor β Chain and Jak1 in Phosphatidylinositol 3-Kinase Recruitment and Phosphorylation , 1998, Molecular and Cellular Biology.
[16] D. Reen,et al. IL‐7 promotes the survival and maturation but not differentiation of human post‐thymic CD4+ T cells , 1998, European journal of immunology.
[17] A. Newton,et al. Regulation of protein kinase C ζ by PI 3-kinase and PDK-1 , 1998, Current Biology.
[18] C Caux,et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. , 1998, Journal of immunology.
[19] A. Strasser,et al. Bcl-2 Can Rescue T Lymphocyte Development in Interleukin-7 Receptor–Deficient Mice but Not in Mutant rag-1 −/− Mice , 1997, Cell.
[20] I. Weissman,et al. Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice , 1997, Cell.
[21] B. Groner,et al. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype , 1996, Molecular and cellular biology.
[22] S. Fesik,et al. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] W. Leonard,et al. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Hanke,et al. Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor , 1996, The Journal of Biological Chemistry.
[25] F. Alt,et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.
[26] H. Griesser,et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.
[27] Augusto Silva,et al. The ζ Isoform of Protein Kinase C Controls Interleukin-2-Mediated Proliferation in a Murine T Cell Line: Evidence for an Additional Role of Protein Kinase C ϵ and β , 1995 .
[28] T. Taniguchi. Cytokine signaling through nonreceptor protein tyrosine kinases. , 1995, Science.
[29] S. Burdach,et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.
[30] W. Leonard,et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. , 1995, Immunity.
[31] R. Abraham,et al. The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line , 1994, The Journal of experimental medicine.
[32] K Y Hui,et al. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.
[33] A. Arcaro,et al. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. , 1993, The Biochemical journal.
[34] A. Feller,et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.
[35] J C Reed,et al. Evidence that protein tyrosine kinase p56-Lck regulates the activity of phosphatidylinositol-3'-kinase in interleukin-2-dependent T-cells. , 1993, The Journal of biological chemistry.
[36] T. Waldmann,et al. Interleukin-2, interleukin-15, and their receptors. , 1998, International reviews of immunology.